featured
The Prevalence and Diagnostic Work-Up of PIK3CA Mutations in HR+/HER2– MBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International journal of breast cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Systematic Review of the Prevalence and Diagnostic Workup of PIK3CA Mutations in HR+/HER2- Metastatic Breast Cancer
Int J Breast Cancer 2020 Aug 01;2020(xx)3759179, EJ Anderson, LE Mollon, JL Dean, TL Warholak, A Aizer, EA Platt, DH Tang, LE DavisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.